High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease - PubMed (original) (raw)
High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease
T Hoshina et al. Scand J Rheumatol. 2008 Nov-Dec.
Abstract
Objective: To investigate whether two proinflammatory cytokines, high mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) are involved in the development of Kawasaki disease (KD).
Methods: Twenty-seven patients with KD were included in this study. Eleven patients with sepsis and 28 healthy children served as controls. Serum levels of HMGB1 and MIF were measured by corresponding enzyme-linked immunosorbent assay (ELISA) kits, respectively. Real-time polymerase chain reaction (PCR) was used to quantify the expression levels of genes encoding receptor for advanced glycation end-products (RAGE), an HMGB1 receptor, and CD74, an MIF receptor in peripheral blood mononuclear cells (PBMCs).
Results: Serum levels of HMGB1 and MIF in KD patients were the highest in the early acute phase and gradually decreased after defervescence. Serum HMGB1 and MIF levels in KD patients were significantly higher than those in controls (HMGB1, p<0.001; MIF, p<0.01). The expression levels of the RAGE gene and CD74 gene in KD patients were significantly higher than those in controls (RAGE, p<0.001; CD74, p<0.01).
Conclusion: These data suggest that HMGB1 and MIF play an important role in immune responses in KD patients.
Similar articles
- Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ, Chun JK, Yeon SI, Shin JS, Kim DS. Lee TJ, et al. Scand J Rheumatol. 2007 May-Jun;36(3):222-5. doi: 10.1080/03009740701218790. Scand J Rheumatol. 2007. PMID: 17657678 - Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation.
Vera PL, Wang X, Meyer-Siegler KL. Vera PL, et al. Exp Biol Med (Maywood). 2008 May;233(5):620-6. doi: 10.3181/0709-RM-240. Epub 2008 Mar 28. Exp Biol Med (Maywood). 2008. PMID: 18375833 - Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H, Hirono K, Ichida F, Vogl T, Ye F, Yanlin X, Saito K, Uese K, Miyawaki T, Viemann D, Roth J, Foell D. Wittkowski H, et al. Arthritis Rheum. 2007 Dec;56(12):4174-81. doi: 10.1002/art.23042. Arthritis Rheum. 2007. PMID: 18050248 - Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor.
Leng L, Bucala R. Leng L, et al. Cell Res. 2006 Feb;16(2):162-8. doi: 10.1038/sj.cr.7310022. Cell Res. 2006. PMID: 16474429 Review. - Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR, Buurman WA, Griffioen AW. van Beijnum JR, et al. Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Angiogenesis. 2008. PMID: 18264787 Review.
Cited by
- High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.
Chirico V, Lacquaniti A, Salpietro V, Munafò C, Calabrò MP, Buemi M, Arrigo T, Salpietro C. Chirico V, et al. Eur J Pediatr. 2014 Sep;173(9):1123-36. doi: 10.1007/s00431-014-2327-1. Epub 2014 May 9. Eur J Pediatr. 2014. PMID: 24809802 Review. - The up-to-date pathophysiology of Kawasaki disease.
Hara T, Yamamura K, Sakai Y. Hara T, et al. Clin Transl Immunology. 2021 May 10;10(5):e1284. doi: 10.1002/cti2.1284. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33981434 Free PMC article. Review. - Epigenetics in Kawasaki Disease.
Sharma K, Vignesh P, Srivastava P, Sharma J, Chaudhary H, Mondal S, Kaur A, Kaur H, Singh S. Sharma K, et al. Front Pediatr. 2021 Jun 25;9:673294. doi: 10.3389/fped.2021.673294. eCollection 2021. Front Pediatr. 2021. PMID: 34249810 Free PMC article. Review. - Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation.
Jia C, Zhang J, Chen H, Zhuge Y, Chen H, Qian F, Zhou K, Niu C, Wang F, Qiu H, Wang Z, Xiao J, Rong X, Chu M. Jia C, et al. Cell Death Dis. 2019 Oct 14;10(10):778. doi: 10.1038/s41419-019-2021-3. Cell Death Dis. 2019. PMID: 31611559 Free PMC article. - Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan.
Murata K, Onoyama S, Yamamura K, Mizuno Y, Furuno K, Matsubara K, Hatae K, Masuda K, Nomura Y, Ohno T, Kinumaki A, Miura M, Sakai Y, Ohga S, Fukushima W, Kishimoto J, Nakamura Y, Hara T. Murata K, et al. Vaccines (Basel). 2021 Jul 30;9(8):839. doi: 10.3390/vaccines9080839. Vaccines (Basel). 2021. PMID: 34451964 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous